Search Results - "Gajula, R.P."

Concurrent Versus Sequential Sorafenib Therapy in Combination With Radiation for Hepatocellular Carcinoma: A Preclinical Study by Wild, A, Gandhi, N, Aziz, K.A, Chettiar, S.T, Gajula, R.P, Kumar, R, Torbenson, M.S, Hales, R.K, Herman, J.M, Tran, P.T

Get full text

Twist1 Overexpression Induces Increased Tumor Cell Aggressiveness and Resistance to Sorafenib in Hepatocellular Carcinoma Cells by Wild, A, Bellovin, D, Chettiar, S.T, Gandhi, N, Gajula, R.P, Williams, R.D, Cades, J.A, Amanda, W.J, Felsher, D.W, Herman, J.M, et al

Get full text

Impact of TWIST1 Transactivation Domain towards Oncogene-Induced Senescence Suppression in Non-Small Cell Lung Cancer by Lafargue, A., Wang, H., Thiruganasambandam, S., Gajula, R.P., Shetty, A.C., Song, Y., Simons, B.W., Nguyen, T., Connis, N., Chowdhury, D.D., Chang, J.H., Council, D.N., Taparra, K., Rezaee, M., Zachara, N., Morris, Z., McFarland, C., Abdulkadir, S.A., Hann, C.L., Tran, P.T.

“…Non-small cell lung carcinoma (NSCLC) is a major cause of cancer mortality. High expression of the epithelial-to-mesenchymal transition transcription factor…”
Get full text

Multi-omics based chronobiological signatures of health risks associated with night shift work by Van Dongen, H., Skene, D.J., McDermott, J.E., Porter, K.I., Koritala, B.S.C., Gajula, R.P., Jacobs, J.M., Bramer, L.M., Kyle, J.E., Metz, T.O., Teeguarden, J., Gaddameedhi, S.

Get full text